Sagent Pharmaceuticals, Inc. and Chongqing Lummy Pharmaceutical Company Announce Development Collaboration

July 11, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

SCHAUMBURG, Ill., July 11, 2011 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced a development collaboration agreement with Chongqing Lummy Pharmaceutical Company (300006:CH). Details of the agreement are confidential.

Twitter
LinkedIn
Facebook
Email
Print

Alliances